Article Details

Poxel Announces the Grant of Patent in China Protecting the Use of Imeglimin for Type ... - BioSpace

Retrieved on: 2025-01-20 21:07:14

Tags for this article:

Click the tags to see associated articles and topics

Poxel Announces the Grant of Patent in China Protecting the Use of Imeglimin for Type ... - BioSpace. View article details on hiswai:

Summary

The article highlights the extension of Poxel SA's patent for Imeglimin in China, focusing on type 2 diabetes and related kidney diseases. This aligns with the biotech key concept by addressing metabolic disorders through innovative treatments.

Article found on: www.biospace.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up